Search Results
Jan 05, 2026, 22:30 ET GIGABYTE dévoile « Refine & Define » qui façonne l'avenir de l'informatique IA lors du CES 2026
contrôle intuitif. GIGABYTE a redessiné l'interface GiMATE, permettant à AI Power Gear III d'effectuer une commutation MUX directe sans entrer dans le BIOS, tandis que GiMATE Creator ajoute des capacités Qwen-image, et GiMATE Coder étend les fonctionnalités de codage intuitif. Les mises à niveau matérielles
More news about: GIGABYTE
Jan 05, 2026, 22:30 ET GIGABYTE ra mắt triết lý "Refine & Define" định hình tương lai điện toán AI tại CES 2026
điều khiển trực quan. GIGABYTE đã làm mới giao diện GiMATE, cho phép AI Power Gear III thực hiện chuyển đổi MUX trực tiếp mà không cần truy cập BIOS, trong khi GiMATE Creator được bổ sung khả năng xử lý hình ảnh Qwen-image, và GiMATE Coder mở rộng các tính năng hỗ trợ lập trình trực quan. Các nâng
More news about: GIGABYTE
Jan 05, 2026, 19:00 ET ASUS Republic of Gamers Presents Next-Gen Gaming Innovations, Commemorates 20 Years of Gaming Excellence at CES 2026
Q-Slot ASUS Thermal Solution - Flexible M.2 heatsink - VRM heatsink design ASUS EZ DIY - BIOS FlashBack™ button - BIOS FlashBack™ LED - ProCool - Pre-mounted I/O shield - SafeSlot Aura Sync -
More news about: ASUS Computer International
Jan 05, 2026, 13:00 ET Eisenhower Fellowships Names 2026 Global Fellows
other fields. Together, they offer bold ideas and a commitment to better their societies at a moment of significant global change. You can read their bios
More news about: Eisenhower Fellowships
Jan 05, 2026, 09:00 ET Lawyers for Justice, P.C. Announces Promotion of Four New Partners as Firm Accelerates Nationwide Growth
Aiwazian added. "That means recognizing leadership, rewarding excellence, and ensuring we have the right people guiding our next chapter."Attorney bios and additional information can be found at
More news about: Lawyers for Justice, P.C.
Dec 31, 2025, 19:00 ET Supermicro Unveils High-Density, Liquid-Cooled and Air-Cooled 6U SuperBlade® Powered by Intel® Xeon® 6900 Series Processors for Maximum Performance and Efficiency
SuperBlade CMM for each blade server. Remote power control capabilities to reboot and/or reset the server are available as well as remote access to the BIOS configuration and operating system console information vial SOL (Serial over LAN) or embedded KVM capabilities. Because the controller is a separate
More news about: Super Micro Computer, Inc.
Dec 23, 2025, 09:00 ET A Slice of Humble Pie: How One Farmer's Harvest-Time Tradition Is Lifting Up Her Community
Pivot Bio's "Pivotal People Inspired by Real Farm Heroes" Series Spotlights Marilyn Backman and her world-famous piesMINNEAPOLIS, Dec. 23, 2025 /PRNewswire/ -- Marilyn Backman isn't your ordinary farmer. Part
More news about: Pivot Bio, Inc
Dec 22, 2025, 02:08 ET Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
safety, tolerability, and pharmacologic profile of ZE00-0388; the evaluation of ZE00-0388 in combination with immune checkpoint inhibitors; and Mondego Bio's development plans and strategic objectives. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties
More news about: Mondego Bio
Dec 19, 2025, 08:43 ET Mercury Bio and Meta-Flux Announce Strategic Collaboration to Advance Large-Molecule Therapeutics for Parkinson's and Alzheimer's Diseases
of Mercury Bio's CNS therapeutics."This partnership allows us to evaluate disease mechanisms and therapeutic hypotheses in a context that has historically been inaccessible," said Lee Sherlock, Chief Executive Officer of Meta-Flux. "By applying our modeling framework to Mercury Bio's CNS programs,
More news about: Mercury Bio Inc. & Meta-Flux
Dec 18, 2025, 13:00 ET Amphix Bio raises $12.5M seed round to advance peptide drug platform
U.S. Food and Drug Administration (FDA), receiving constructive feedback on preclinical safety studies and clinical trial design. In addition, Amphix Bio's drug-device combination product for the treatment of degenerative disc disease, AMFX-100, received Breakthrough Device Designation from the FDA.Advancement
More news about: Amphix Bio
Dec 17, 2025, 11:00 ET PRISM BioLab and Talus Bioscience Join Forces to Discover Novel Inhibitors of Transcription Factor and Protein-Protein Interaction Targets
entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and protein-protein interaction (PPI) targets. By combining Talus Bio's assay technologies for screening for TF and PPI inhibitors in native cellular environment with PRISM's chemistry designed to target protein-protein
More news about: PRISM Biolab
Dec 17, 2025, 07:00 ET Bioptimus Unveils M-Optimus, a World Model for Biology
https://www.bioptimus.com/newsLeadership Bios –
More news about: Bioptimus
Dec 17, 2025, 07:00 ET Bioptimus Unveils M-Optimus, a World Model for Biology
https://www.bioptimus.com/newsLeadership Bios –
More news about: Bioptimus
Dec 15, 2025, 20:21 ET Shareholder Alert: The Ademi Firm investigates whether Generation Bio Co. is obtaining a Fair Price for its Public Shareholders
entitle holders to receive portions of net cash above $29 million at closing, potential savings from Generation Bio's Cambridge office lease obligations, and proceeds from Generation Bio's existing license agreement with Moderna, which includes development and commercial milestones and royalties.Generation
More news about: Ademi LLP
Dec 15, 2025, 09:05 ET Pivot Bio Announces Additions to Senior Management
product operations and execution, Katie Liberatore will drive cross-functional alignment, operational excellence and strategic execution across Pivot Bio's R&D portfolio. At the same time, she will play a critical role in ensuring the company brings forward high-impact innovations efficiently, effectively
More news about: Pivot Bio, Inc
Dec 15, 2025, 08:30 ET Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
therapies, establishing the pathway toward an off-the-shelf product in a much more scalable and efficient in vivo format. By combining Leucid Bio's pan-cancer CAR-T with our targeted delivery system, we aim to significantly improve treatment options for patients battling solid tumours."About
More news about: Leucid Bio
Dec 12, 2025, 09:00 ET Strategic Partnership | Sanyou Bio and KanryBio Forge Partnership to Co-Develop Key Reagents and Products for Biomarker Assay Kits
collaboration agreement. The partnership will focus on the joint development of key reagents and products for biomarker assay kits. By integrating Sanyou Bio's core strengths in innovative biologics discovery with KanryBio's expertise in kit product development and manufacturing, the collaboration aims to provide
More news about: Sanyou Bio
Dec 11, 2025, 09:03 ET Sōlaria Biō Announces Breakthrough Study Demonstrating Connection Between Gut Barrier, Inflammation and Bone Health
understanding how targeting inflammation in the gut can measurably improve bone density and protect against age-related bone loss and reflect Sōlaria Biō's commitment to science-first, transparent, rigorous R&D. In the continued pursuit of scientific advancement of bone health, Sōlaria Biō is
More news about: Sōlaria Biō
Dec 11, 2025, 07:30 ET Brii Biosciences and OpenBench Announce AI-Driven Collaboration for Proprietary Technology Platform
program criteria for success," said James Yoder, CEO at OpenBench. "We are pleased to support Brii Bio's mission to develop transformative therapies for patients and feel confident we can advance Brii Bio's research pipeline.""OpenBench's structure-based AI platform represents a powerful tool to
More news about: OpenBench; Brii Biosciences
Dec 11, 2025, 07:30 ET TuHURA Biosciences Provides Corporate Update Following Recent Financing
or an inhibiting antibody, and inhibition of menin signaling pathway significantly improves survival in murine models of AMLSpeaker Bios:Tae Kon Kim, MD, PhD, Assistant Professor of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical
More news about: TuHURA Biosciences, Inc.
Dec 11, 2025, 04:54 ET Hullo Announces Major Upgrade to Its AI Matchmaking System, Backed by Participation in Nvidia Inception, AWS Activate, and Google for Startups
connect beyond text and images.AI-Assisted Profile CreationFor those who struggle with writing bios, Hullo includes an integrated AI Bio generator that helps users
More news about: Hullo Dating Co.,ltd
Dec 10, 2025, 09:05 ET Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006
Bio today announced Formation Bio's acquisition of worldwide rights, excluding Greater China, to LNK01006, a next generation central nervous system (CNS)–penetrant highly selective TYK2 inhibitor. The asset will be developed within Formation Bio's newly formed subsidiary Bleecker Bio.
More news about: Lynk Pharmaceuticals Co., Ltd.
Dec 10, 2025, 09:00 ET Formation Bio Licenses Phase 1-Ready CNS Penetrant TYK2 Inhibitor from Lynk Pharmaceuticals
Acquisition adds a highly differentiated clinical stage asset to Formation Bio's rapidly expanding portfolio of immunology programsNEW YORK, Dec. 10, 2025 /PRNewswire/ --
More news about: Formation Bio
Dec 09, 2025, 20:30 ET D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
MPCi, and Medicxi — also contributed to the round. The robust involvement from both new and current investors highlights widespread confidence in D3 Bio's innovative pipeline and its global development strategy.Proceeds from this financing will primarily support the planned global Phase III pivotal
More news about: D3 Bio, Inc.
Dec 09, 2025, 15:18 ET Rockstar Energy Open Announces Westend and Torren Foot as Live Music Headliners for Inaugural Snowboarding Event
ThePlatfrm.com and broadcast globally via Platfrm channels, ProSieben, FuelTV and more.For the most updated information, to view athlete bios,
More news about: Rockstar Energy Drink